Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Steven Pincus
Observed names:
Pincus, Steven E.,
S PINCUS,
STEVEN E. PINCUS,
STEVEN PINCUS,
Steven E Pincus,
Steven E. Pincus
show all 6
Institution:
Novavax (United States)
Observed institutions:
State University of New York,
University of Miami,
Novavax (United States),
Elusys Therapeutics (United States),
University of Virginia,
Stony Brook University,
University at Buffalo, State University of New York,
University of Pennsylvania
show all 8
OpenAlex ID:
A5112870222
Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection
1991
·
Peter W. Mason
, Steven Pincus
, et al.
·
Virology
·
205
Mice immunized with a subviral particle containing the japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection
1992
·
Eiji Konishi
, Steven Pincus
, et al.
·
Virology
·
179
PDF
Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico
2011
·
Constantino López-Macías
, Eduardo Ferat-Osorio
, et al.
·
Vaccine
·
150
PDF
A High-Affinity Monoclonal Antibody to Anthrax Protective Antigen Passively Protects Rabbits before and after Aerosolized Bacillus anthracis Spore Challenge
2005
·
Nehal Mohamed
, Michelle Clagett
, et al.
·
Infection and Immunity
·
136
Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis
1992
·
Steven Pincus
, Peter W. Mason
, et al.
·
Virology
·
134
Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus
1991
·
Eiji Konishi
, Steven Pincus
, et al.
·
Virology
·
111
A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine
1992
·
Eiji Konishi
, Steven Pincus
, et al.
·
Virology
·
107
PDF
H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans
2011
·
Surender Khurana
, Jian Wu
, et al.
·
Journal of Virology
·
104
Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice
1994
·
Benedito A.L. Fonseca
, Steven Pincus
, et al.
·
Vaccine
·
101
PDF
Human complement receptor type 1–directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis
2006
·
Sergei Zaitsev
, Kristina Danielyan
, et al.
·
Blood
·
70
Characterization of the effect of aphidicolin on adenovirus DNA replication: evidence in support of a protein primer model of initiation
1981
·
Steven Pincus
, Warren Robertson
, et al.
·
Nucleic Acids Research
·
63
PDF
Poxvirus-Based Vectors as Vaccine Candidates
1995
·
Steven Pincus
, James Tartaglia
, et al.
·
Biologicals
·
59
Guanidine-dependent mutants of poliovirus: Identification of three classes with different growth requirements
1987
·
Steven E. Pincus
, Holger Rohl
, et al.
·
Virology
·
59
Molecular Events Leading to Picornavirus Genome Replication
1987
·
Eckard Wimmer
, Richard J. Kuhn
, et al.
·
Journal of Cell Science
·
54
Recognition of Dengue Virus NS1-NS2a Proteins by Human CD4+ Cytotoxic T Lymphocyte Clones
1997
·
Sharone Green
, Ichiro Kurane
, et al.
·
Virology
·
40
PDF
Metabolism of monofluoro- and monochlorobenzoates by a denitrifying bacterium
1979
·
Barrie F. Taylor
, W. Lee Hearn
, et al.
·
Archives of Microbiology
·
39
Influenza virus-like particles as a new tool for vaccine immunogenicity testing: Validation of a neuraminidase neutralizing antibody assay
2011
·
Victor Gavrilov
, Tatyana Orekov
, et al.
·
Journal of Virological Methods
·
17
Live Attenuated Vaccinia and Other Poxviruses as Delivery Systems: Public Health Issues
1995
·
MARION E. PERKUS
, JILL TAYLOR
, et al.
·
Annals of the New York Academy of Sciences
·
16
Heteropolymers: a novel technology against blood-borne infections.
2005
·
Nehal Mohamed
, Steven M Jones
, et al.
·
PubMed
·
12
The Polio virus Genome: A Unique RNA in Structure, Gene Organization, and Replication
1987
·
STEVEN E. PINCUS
, RICHARD J. KUHN
, et al.
·
Elsevier eBooks
·
8
The inhibition of both initiation and elongation of adenovirus DNA replication by actinomycin D
1984
·
Steven Pincus
, David Rekosh
·
Biochemical and Biophysical Research Communications
·
5
A Suspension Vero Cell Line for Production of Viral Vaccines and Viral Therapeutics
2018
·
Steven Pincus
, Cari Sadowski
, et al.
·
BioProcessing Journal
·
2
A ddPCR primer: advantages, challenges, and key considerations when adopting Droplet Digital PCR for viral vector manufacture
2021
·
, ,
, Lauren M Drouin
, et al.
·
Cell and Gene Therapy Insights
Understanding the multiple platforms available for production of virus vaccines and therapeutics
2016
·
Steven E Pincus
·
Journal of Vaccines & Vaccination
1 Heteropolymers: a New Class of Therapeutics for Treating Lethal Bacterial and Viral Infections
2004
·
Mohamed, Nehal
, Jones, Steven M.
, et al.
Show more works
View as search
Works count:
27
Citation count:
1,671
H-index:
17
I10-index:
19
Year
Topic
Type